Diagnostics (May 2022)

Image-Guided Percutaneous Ablation for Primary and Metastatic Tumors

  • Arian Mansur,
  • Tushar Garg,
  • Apurva Shrigiriwar,
  • Vahid Etezadi,
  • Christos Georgiades,
  • Peiman Habibollahi,
  • Timothy C. Huber,
  • Juan C. Camacho,
  • Sherif G. Nour,
  • Alan Alper Sag,
  • John David Prologo,
  • Nariman Nezami

DOI
https://doi.org/10.3390/diagnostics12061300
Journal volume & issue
Vol. 12, no. 6
p. 1300

Abstract

Read online

Image-guided percutaneous ablation methods have been further developed during the recent two decades and have transformed the minimally invasive and precision features of treatment options targeting primary and metastatic tumors. They work by percutaneously introducing applicators to precisely destroy a tumor and offer much lower risks than conventional methods. There are usually shorter recovery periods, less bleeding, and more preservation of organ parenchyma, expanding the treatment options of patients with cancer who may not be eligible for resection. Image-guided ablation techniques are currently utilized for the treatment of primary and metastatic tumors in various organs including the liver, pancreas, kidneys, thyroid and parathyroid, prostate, lung, bone, and soft tissue. This article provides a brief review of the various imaging modalities and available ablation techniques and discusses their applications and associated complications in various organs.

Keywords